NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £616,714,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 18 Mar 2025 |
| Procedure | open |
| OCID | ocds-h6vhtk-04dd23 |
Awards (28)
This procurement was awarded to 28 suppliers. Values shown are per-award; the notice total is £616,714,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | · | · | active |
| Amgen Ltd shared | · | · | active |
| AstraZeneca shared | · | · | active |
| Aventis Pharma ltd t/a Sanofi shared | · | · | active |
| Bayer Plc shared | · | · | active |
| Biogen shared | · | · | active |
| Chugai Pharma UK Ltd shared | · | · | active |
| CST Pharma Limited shared | · | · | active |
| Dr.Reddy's Laboratories (UK) Limited shared | · | · | active |
| Eli Lilly and Company Ltd shared | · | · | active |
| Gedeon Richter UK Ltd shared | · | · | active |
| GlaxoSmithKline UK Limited shared | · | · | active |
| Janssen-Cilag Ltd shared | · | · | active |
| Manx Healthcare Ltd shared | · | · | active |
| Merck Serono Limited shared | · | · | active |
| Mylan shared | · | · | active |
| Napp Pharmaceuticals Ltd shared | · | · | active |
| Novo Nordisk shared | · | · | active |
| Orifarm UK shared | · | · | active |
| Pfizer Ltd shared | · | · | active |
| Pharmacosmos UK Ltd shared | · | · | active |
| Roche Products Ltd shared | · | · | active |
| Sandoz Ltd shared | · | · | active |
| Seqirus UK Limited shared | · | · | active |
| Sun Pharma UK Ltd shared | · | · | active |
| Teva UK Limited shared | · | · | active |
| Thornton and Ross Ltd shared | · | · | active |
| Vifor Pharma UK Ltd shared | · | · | active |
description
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025<br/>CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines – Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027<br/>CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines – Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026
documents
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/0611e16a-d816-4f52-ac39-00cd9f81e448
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/0d2d91a8-7cc4-411e-a9ff-a6338b158cbd
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/10db3c90-6ce9-4ce1-8b54-0368eaaccd5e
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/1bd3014c-7ab8-4923-bc24-8d01bc73fc9e
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/2a66c2e8-7015-4426-9430-ef152e8ab8f4
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/6dace33d-afb7-4f1b-90e2-03b0f72289a1
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/71fadff2-366b-41d3-9d35-76aa6fa3c366
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/88f9883f-434f-45a0-b5ec-e565565a44f8
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/99669839-f665-4959-a510-4d61c1809b31
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/cdce8daf-bccb-4e1d-9ccc-c2dc17030a94
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/d0926863-d575-41d2-a082-911f39cc37f7
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/d581d007-f951-401f-a106-ca7766b8b319
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/d934f879-26d7-45e7-bd1b-25724243f1af
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/d9af8346-4bdc-4896-b4b0-4284919eef20
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/ecb51930-ba94-4d12-b016-943747587432
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/f0fc7043-0c88-4298-a5b7-3aacbdae4d46
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/f9a25192-7f6b-47df-a874-2cda30200ed0
- https://www.contractsfinder.service.gov.uk/Notice/f9c7cd10-8609-424e-ad3c-206926b976c0 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 10 Feb 2025 | Contract notice (F02) | Earlier regulations | 004304-2025 |
| 10 Feb 2025 | Tender (tender) | · | f9c7cd10-8609-424e-ad3c-206926b976c0-824771 |
| 24 Jul 2025 | Contract award notice (F03) | Earlier regulations | 042580-2025 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.